Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 12:22 AM
NCT ID:
NCT07263958
Eligibility Criteria:
Inclusion Criteria:
* Age 40 years or older.
* Established diagnosis of severe or very severe Chronic Obstructive Pulmonary Disease (COPD), corresponding to GOLD stage 3 or 4.
* Symptomatic Group 3 Pulmonary Hypertension (PH) confirmed by Right Heart Catheterization (RHC) with the following hemodynamic profile at rest:
* Mean Pulmonary Artery Pressure (mPAP) \> 35 mmHg.
* Pulmonary Vascular Resistance (PVR) \> 5 Wood Units (WU).
* Pulmonary Capillary Wedge Pressure (PCWP) ≤ 15 mmHg.
* Capable of providing written informed consent.
Exclusion criteria:
* History of hypersensitivity to iloprost or other prostacyclin analogs.
* Pregnancy or breastfeeding.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
40 Years
Study:
NCT07263958
Study Brief:
Protocol Section:
NCT07263958